139 related articles for article (PubMed ID: 37865960)
21. HSC-derived exosomal miR-199a-5p promotes HSC activation and hepatocyte EMT via targeting SIRT1 in hepatic fibrosis.
Lu H; Zhang R; Zhang S; Li Y; Liu Y; Xiong Y; Yu X; Lan T; Li X; Wang M; Liu Z; Zhang G; Li J; Chen S
Int Immunopharmacol; 2023 Nov; 124(Pt B):111002. PubMed ID: 37804655
[TBL] [Abstract][Full Text] [Related]
22. Extracellular vesicles-derived miR-150-5p secreted by adipose-derived mesenchymal stem cells inhibits CXCL1 expression to attenuate hepatic fibrosis.
Du Z; Wu T; Liu L; Luo B; Wei C
J Cell Mol Med; 2021 Jan; 25(2):701-715. PubMed ID: 33342075
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of miR-20b-5p Contributes to the Progression of Liver Fibrosis via the STAT3 Signaling Pathway In Vivo and In Vitro.
Lv L; Wang D; Yin J; Yang T; Huang B; Cao Y; Lu J
Dig Dis Sci; 2023 Feb; 68(2):487-496. PubMed ID: 35947307
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-125a-5p Contributes to Hepatic Stellate Cell Activation through Targeting FIH1.
Li G; Li J; Li C; Qi H; Dong P; Zheng J; Yu F
Cell Physiol Biochem; 2016; 38(4):1544-52. PubMed ID: 27074047
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
[TBL] [Abstract][Full Text] [Related]
26. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
[TBL] [Abstract][Full Text] [Related]
27. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
28. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
[TBL] [Abstract][Full Text] [Related]
29. miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis.
Huang CF; Sun CC; Zhao F; Zhang YD; Li DJ
J Gastroenterol; 2015 Apr; 50(4):480-90. PubMed ID: 25155445
[TBL] [Abstract][Full Text] [Related]
30. Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p.
Chen L; Chen R; Velazquez VM; Brigstock DR
Am J Pathol; 2016 Nov; 186(11):2921-2933. PubMed ID: 27662798
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
32. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing.
Liu X; Ma H; Wu R; Wang H; Xu H; Li S; Wang G; Lv G; Niu J
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553468
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88.
Xu T; Pan L; Li L; Hu S; Zhou H; Yang C; Yang J; Li H; Liu Y; Meng X; Li J
J Cell Mol Med; 2020 Jul; 24(13):7127-7140. PubMed ID: 32463570
[TBL] [Abstract][Full Text] [Related]
34. miR-96-5p prevents hepatic stellate cell activation by inhibiting autophagy via ATG7.
Yu K; Li N; Cheng Q; Zheng J; Zhu M; Bao S; Chen M; Shi G
J Mol Med (Berl); 2018 Jan; 96(1):65-74. PubMed ID: 29051972
[TBL] [Abstract][Full Text] [Related]
35. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation.
Sun X; He Y; Ma TT; Huang C; Zhang L; Li J
Mol Cell Biochem; 2014 Mar; 388(1-2):11-23. PubMed ID: 24242045
[TBL] [Abstract][Full Text] [Related]
36. Anti-Liver Fibrosis Role of miRNA-96-5p via Targeting FN1 and Inhibiting ECM-Receptor Interaction Pathway.
Zhang Y; Gu T; Xu S; Wang J; Zhu X
Appl Biochem Biotechnol; 2023 Nov; 195(11):6840-6855. PubMed ID: 36943602
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
[TBL] [Abstract][Full Text] [Related]
38. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA interplay between hepatic stellate cell quiescence and activation.
Ezhilarasan D
Eur J Pharmacol; 2020 Oct; 885():173507. PubMed ID: 32858048
[TBL] [Abstract][Full Text] [Related]
40. The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl
Liao J; Zhang Z; Yuan Q; Luo L; Hu X
Toxicol Lett; 2022 Jun; 362():38-49. PubMed ID: 35483553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
